Cui et al. found that the increase of FTO in esophageal squamous cell carcinoma (ESCC) inhibited the decay of LINC00022 through m6A reader YTHDF2, thus, promoting cell cycle progression and proliferation (Cui et al., 2021). This evidence concerns the gene YTHDF2 and esophageal squamous cell carcinoma.